Literature DB >> 20485192

Validation of genetic association in apelin-AGTRL1 system with hypertension in a larger Han Chinese population.

Wenquan Niu1, Shengnan Wu, Yi Zhang, Weiwei Li, Kaida Ji, Pingjin Gao, Dingliang Zhu.   

Abstract

BACKGROUND AND
OBJECTIVE: We have recently resequenced apelin and AGTRL1 genes to identify candidate polymorphisms in family-based association with hypertension and related phenotypes. In this study, we aimed to determine and replicate these polymorphisms via a larger, independent case-control study in Shanghai Han Chinese.
METHODS: Two polymorphisms [rs3761581 (A/C) and T-1860C] in apelin gene and two [rs7119375 (G/A), rs10501367 (G/A)] in AGTRL1 gene were genotyped using the TaqMan assay among 969 patients diagnosed with essential hypertension and 980 age and sex-matched controls. Data were analyzed using Haplo.stats program.
RESULTS: In single-locus analysis, significant differences were observed in allele distribution of rs3761581 (P = 0.0156) in men and in rs7119375 (P = 0.0488) genotype distribution in women between patients and controls. Haplotype analysis indicated that haplotypes C-C-G-G (in order of T-1860C, rs3761581, rs7119375 and rs10501367) [adjusted odds ratio (ORadjusted) = 1.67, P = 0.0061] and T-A-A-A (ORadjusted = 1.62, P = 0.0008) conferred an increased risk for hypertension after adjustment for age, onset age, body mass index (BMI) and waist-to-hip ratio, whereas haplotype C-C-A-A (ORadjusted = 0.33, P = 0.0048) conferred a protective effect. In women, increased risk for hypertension was seen for haplotypes T-A-G-G (ORadjusted = 1.30, P = 0.0051), C-C-G-G (ORadjusted = 2.86, P < 0.0001), T-A-A-A (ORadjusted = 1.66, P = 0.0003) and C-C-A-A (ORadjusted = 2.65, P < 0.0001), whereas decreased risk was seen for haplotypes C-A-G-G (ORadjusted = 0.48, P < 0.0001) and T-C-G-G (ORadjusted = 0.40, P < 0.0001). Further haplotype-phenotype analyses indicated the robustness of these associations. For example, haplotype T-A-A-A was significantly associated with obesity index (BMI and waist-to-hip ratio) in both sexes and blood pressures in men (P-sim < 0.05).
CONCLUSION: In this exploratory pilot case-control study, we found robust haplotype-based and haplotype-phenotype associations of four well characterized polymorphisms in apelin-AGTRL1 system with hypertension and related phenotypes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20485192     DOI: 10.1097/HJH.0b013e32833b1fad

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  21 in total

Review 1.  Apelin and insulin resistance: another arrow for the quiver?

Authors:  Shiming Xu; Philip S Tsao; Patrick Yue
Journal:  J Diabetes       Date:  2011-09       Impact factor: 4.006

2.  Common variants in TGFBR2 and miR-518 genes are associated with hypertension in the Chinese population.

Authors:  Jinfeng Chen; Xianghai Zhao; Hairu Wang; Yanchun Chen; Wen Wang; Wei Zhou; Xuecai Wang; Junming Tang; Yanping Zhao; Xiangfeng Lu; Shufeng Chen; Laiyuan Wang; Chong Shen; Song Yang
Journal:  Am J Hypertens       Date:  2014-03-31       Impact factor: 2.689

3.  The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans-inhibition.

Authors:  K Siddiquee; J Hampton; D McAnally; Lt May; Lh Smith
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

4.  Tag polymorphisms of solute carrier family 12 member 3 gene modify the risk of hypertension in northeastern Han Chinese.

Authors:  Y L Wang; Y Qi; J N Bai; Z M Qi; J R Li; H Y Zhao; Y F Wang; C Z Lu; Y Xiao; N Jia; B Wang; W Q Niu
Journal:  J Hum Hypertens       Date:  2014-01-16       Impact factor: 3.012

5.  Characterization of the apelin -1860T>C polymorphism in Turkish coronary artery disease patients and healthy individuals.

Authors:  Raziye Akcılar; Gündüz Yümün; Zeynep Bayat; Okan Donbaloğlu; Kubilay Erselcan; Ezgi Ece; Hülya Kökdaşgil; Osman Genç
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2015-12-25

6.  Evaluation of Transforming Growth Factor Beta-1 Gene 869T/C Polymorphism with Hypertension: A Meta-Analysis.

Authors:  Wenquan Niu
Journal:  Int J Hypertens       Date:  2011-07-14       Impact factor: 2.420

Review 7.  International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand.

Authors:  Cai Read; Duuamene Nyimanu; Thomas L Williams; David J Huggins; Petra Sulentic; Robyn G C Macrae; Peiran Yang; Robert C Glen; Janet J Maguire; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

8.  Interactive association of five candidate polymorphisms in Apelin/APJ pathway with coronary artery disease among Chinese hypertensive patients.

Authors:  Wei Jin; Xiuxiu Su; Min Xu; Yan Liu; Jingyi Shi; Lin Lu; Wenquan Niu
Journal:  PLoS One       Date:  2012-12-03       Impact factor: 3.240

9.  Associations of common variants at APLN and hypertension in Chinese subjects with and without diabetes.

Authors:  Rong Zhang; Jingyi Lu; Cheng Hu; Congrong Wang; Weihui Yu; Feng Jiang; Shanshan Tang; Yuqian Bao; Kunsan Xiang; Weiping Jia
Journal:  Exp Diabetes Res       Date:  2012-12-17

10.  Associations of plasma atrial natriuretic peptide and electrolyte levels with essential hypertension.

Authors:  Guangmei Hu; Xinjuan Xu; Xiaohui Liang; Xiaoping Yang; Junshi Zhang; Zhulepiya Simayi; Yulan Chen
Journal:  Exp Ther Med       Date:  2013-03-06       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.